The Boston Red Sox’s decision to trade Chris Sale to the Atlanta Braves in exchange for Vaughn Grissom during the offseason was initially seen as a strategic move that could benefit both teams.
Sale, a pitcher with undeniable talent but plagued by injuries, had only managed 31 starts over the previous four seasons, making him a risky asset for Boston. Grissom, a young infielder with potential, seemed like a promising acquisition, especially considering his limited opportunities in Atlanta due to their infield depth.
However, the trade has turned out to be a regrettable one for the Red Sox. Chris Sale has found his form with the Braves, performing at an elite level reminiscent of his prime, while Boston is paying $17 million of his salary, with the Braves covering only $500,000.
This would have been less painful for Boston if Grissom had delivered on his promise. Instead, he has struggled significantly, hitting just .148 in 81 at-bats before landing on the injured list twice due to hamstring issues.
Grissom’s absence and poor performance have only highlighted the lopsided nature of the trade. His rehab stint in Triple-A has shown little sign of improvement, and there’s a possibility Boston may keep him in the minors after his recovery.
The Red Sox might have tolerated Sale’s resurgence if Grissom had shown potential as their future second baseman, but with both Sale thriving in Atlanta and Grissom faltering, the deal has become a source of significant regret for Boston.
